Health Care Quality, Access, and Evaluation: News and Research on Outcome Assessment, Health Care

MeSH tree: N05.715.360.575.575

FDA approves Inlexzo for bladder cancer

The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.

page 6 from 19